搜索到 1000 条关于 ㎗소라넷㎌rhX667¸TOp㎚천안 휴게털㎢잠실 op추천◀양양 마이펫▣연천 섹파찾기┘해운대 핸플 的文章

2012.09.19 2nd Asia-Pacific Osteoporosis and Bone Meeting

会议简介 WelcomeThe Presidents of IOF and ANZBMS along with the Local Organising Committee are pleased to invite you to participate in the IOF Regionals - 2nd Asia-Pacific Osteoporosis and Bone Meeting being held in conjunction with the ANZBMS Annual Scientific Meeting and JSBMR in September 4-8, 2011.The Asia-Pacific region is the largest growth market in the world in the bone field. As revealed by the IOF Asian Audit in 2009, it is anticipated that by 2050 more than 50% of all osteoporotic fractures will occur in Asia.With an active Asia-Pacific Office and 28 member societies from the Region,? IOF Regionals provide the first and only? annual opportunity for a truly Regional Meeting to occur in the Asia-Pacific Region.? IOF Meetings focus on clinical treatment of osteoporosis as well as cutting edge science in the field. ANZBMS meetings are the peak Bone and Mineral professional events in the Australian and New Zealand region and JSBMR serves the entire Japanese community with annual scientific meetings in the area of bone and mineral research.The Meeting format includes plenary sessions, abstract presentations, poster presentations and viewing, Meet-the-Expert sessions, satellite symposia, award presentations, workshops and several social events.We hope to see you there!John A. Kanis,
President - International Osteoporosis FoundationRebecca Mason,
President - Australian and New Zealand Bone & Mineral Society
Program ? ?
Please see below for a draft program at a glance and preliminary seminar topics and associated titles. Please keep posted for more program details.PROGRAM AT A GLANCE - Please click here for a downloadable program at a glanceSEMINAR TOPICS
  • Biomechanics and Bone Measurement
  • Mark Forwood , "Why bones fail: structure and mechanics"
  • Ego Seeman , "Measuring microarchitecture"
  • Clinical Management of Osteoporosis I
  • Hiroshi Hagino , "Incidence and prevention of second hip fracture in Japan"
  • John Kanis , "To BMD or not to BMD?
  • Markus Seibel , "Fracture liaison services"
  • Clinical Osteoporosis Management II
  • Jacqui Center , "Osteoporosis Management and Mortality"
  • Toshio Matsumoto , "New strategies for treatment of osteoporosis"
  • Philip Sambrook , "Osteoporosis:? what should we measure, what should we check, whom should we treat, and with what?"
  • Fracture Risk Algorithms: Soothsaying or Science?
  • Emma Duncan , "Genetics, bones and fracture"
  • John Kanis , Getting to Grips with FRAX: how it really works
  • Male Osteoporosis
  • Shigeaki Kato , "Estrogens, androgens and bone"
  • Eric Orwoll , "Osteoporosis in men"
  • Malignancy and Bone
  • Cory Xian , "Mechanisms and prevention for cancer chemotherapy-induced bone defects"
  • Toshio Yoneda , "Bone pain associated with cancer metastasis to bone"
  • Andrew Zannetino , "Myeloma and bone"
  • Non-Canonical Bone
  • Paul Baldock , "Bones and brains"
  • Caryl Nowson , "Bones and salt: the renin/angiotensin/aldosterone axis in bone"
  • Matthew Warman , "LRP5, serotonin and bone"
  • Osteoclasts
  • Natalie Sims , "Osteoblastic support of osteoclasts"
  • Nao Takahashi , "Quiescent osteoclast precursors"
  • Sanuo Takeshita , "Couplin"
  • Sakae Tanaka , "Regulation of activity and apoptosis of osteoclasts"
  • Osteoporosis in Oceania / Asia Pacific Region
  • Cyrus Cooper, "Secular trends in fracture incidence: Why are fractures increasing in Asia but falling in the West?"
  • Edith Lau , "Strategies for fracture prevention in Asia - where do we go from here?"
  • Ambrish Mithal , "Strategies to overcome epidemic of Vitamin D deficiency in Asia"
  • Paediatric Bone Disease
  • Christopher Cowell , "Measuring a growing skeleton, and the effect of ethnicity on bone and body composition"?
  • Keiichi Ozono , "Osteoporosis and Osteopetrosis in the young"
  • Tania Winzenberg , "Nutrition and bone in children"
  • Paget''s Disease
  • Tim Cundy , "The epidemiology of Paget''s disease"
  • Stuart Ralston , "The genetics of Paget''s disease"
  • Rheumatology and Bone
  • Steven Goldring , "Inflammation and bone resorption in Rheumatoid Arthritis"
  • Hiroshi Takayanagi , "Osteoimmunology"
  • Gethin Thomas , "Inflammation and bone formation in Ankylosing Spondylitis"
  • Skeletal Dysplasias
  • Seiji Fukumoto , "Hypophosphataemia and FGF23"
  • Matthew Warman , "Mouse models for Skeletal Dysplasias"
  • Andreas Zankl , "Skeletal dysplasias: a new approach"
  • The Effects of Ageing
  • Neil Binkley , "Sarcopaenia and ageing"
  • David Scott , "Sarcopaenia and Vitamin D"
  • Therapeutics in Osteoporosis: Controversies
  • Peter Ebeling , "The perils and pitfalls of antiresorptives"
  • Satoshi Mori , "Fracture healing- tissue changes with bisphosphonates"
  • Alvin Ng , "Atypical Subtrochanteric and Diaphyseal Femoral Fractures - What We Know and What We Don''t"
  • Speaker to be confirmed , "The positives of bisphosphonates"
  • Workshop on Bone Regeneration
  • Simon Cool , "Stem cells and fracture repair"
  • Yunfeng Lin , "Adipose Stem Cells and Craniofacial Regeneration"
  • Hala Zreiqat , "A basis for building bone:? novel nanocomposite scaffolds for new bone growth"
2017 年 6 月 JCO 在线肿瘤研究进展速递

2017.07.13 2017 年 6 月 JCO 在线肿瘤研究进展速递

TOP2A 正常乳腺癌患者的 DBCG 07-READ 研究:多中心开放标签 III 期研究中,2012 名早期 TOP2A 正常的乳腺癌患者随机接受 6 周期...,无远处转移生存,死亡率都没有显著差异。3 级肿瘤从 DC 获益更多,1~2 级肿瘤从 EC-D 获益更多。证实早期 TOP2A 正常乳腺癌患者从辅助蒽环类药物
武汉成医药科技前沿技术聚集地,「国之重器」亮相健博会

2019.04.11 武汉成医药科技前沿技术聚集地,「国之重器」亮相健博会

;go.Top 新型未来CT、静脉麻醉药瑞马唑仑和口服靶向抗肿瘤药吡咯替尼正式亮相。发布会上,西门子医疗系统有限公司、江苏恒瑞医药股份有限公司作为代表企业,分别发布各自的全新产品。SOMATOMgo.Top 新型未来CT 采用集成化的诊断平台,不仅
丁香园独家专访沃芬公司副总裁 Gilles Castera:引领中国市场,满足用户需求

2018.06.13 丁香园独家专访沃芬公司副总裁 Gilles Castera:引领中国市场,满足用户需求

流水线,它整合了全球领先的全自动凝血分析仪 ACL TOP 700 LAS、市场上最完善的凝血检测菜单 HemosIL、专为凝血实验室设计的智能数据管理系统... 月底,新一代全自动凝血分析仪 ACL TOP Family 50 系列产品即将来到中国,这是全球第一个具有项目特异性分析前样本质量核查功能的凝血分析仪,被誉为

2017.08.15 IDMF 第二届中国国际药品微生物高峰论坛

——制药企业质量负责人(国内大型)Quality head from top domestic company4、16:10-17:00无菌工艺关键... top 500 company17:00-17:20 演讲专家集体交流答疑 Experts Answering Questions17

2014.08.19 Pharm Mach 国际制药机械展

》杂志、约见医药界以及PITOP100医药行业创新力评选等多渠道媒体品牌的大力推动下,「PharmMach国际制...!制药装备行业发展论坛医药包装创新论坛制药环保与洁净论坛最新制药机械、包装设备产品购销推介会「PITOP100」十大制药装备

2014.07.28 「Contract Pharm 合同定制服务展」

《医药界》杂志、约见医药界以及PI TOP 100创新力评选等多渠道媒体品牌的大力推动下,「Contract Pharm 合同定制服务展」为企业打造了一个专业的...专场贸易配对会新产品、新技术推介会「PI TOP 100 」十大最具投资价值CRO企业颁奖盛典更多活动策划中,最新信息请关注
印度版抗癌药代购难禁:售价仅为合法药十分之一

2014.06.30 印度版抗癌药代购难禁:售价仅为合法药十分之一

靶向药物。2013年全球最畅销抗肿瘤药物TOP20中的靶向药物市场销售规模合计326.78亿美元,占到抗肿瘤药物TOP20的64.45%。所谓海外代购抗癌药
不得不说的“SCI论文”

2013.01.15 不得不说的“SCI论文”

,大家也同样清楚,潜在的就是存在很大不确定性的。世道就是这么颠覆的!当有人把“引用TOP100”看作“TOP100”时

2012.01.31 吴国清:不得不说的“SCI论文”

,大家也同样清楚,潜在的就是存在很大不确定性的。世道就是这么颠覆的!当有人把“引用TOP100”看作“TOP100”时
上一页 1 2 3 ... 44 45 46 ... 48 49 50 下一页 到第